| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImageneBio, Inc. | Chief Financial Officer | Common Stock | 11,146 | $191,265 | $17.16 | 28 Jul 2025 | Direct |
| Aptose Biosciences Inc. | Senior VP, CFO, and CBO | Employee Stock Option | 600,000 | 18 Jan 2022 | Direct | ||
| Aptose Biosciences Inc. | Senior VP, CFO, and CBO | Performance Stock Option | 200,000 | 19 Aug 2021 | Direct | ||
| ImageneBio, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 25 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IKNA | ImageneBio, Inc. | 25 Jul 2025 | 5 | -$79,451 | 4 | Chief Financial Officer | 29 Jul 2025, 21:32 |
| IKNA | Ikena Oncology, Inc. | 01 Feb 2024 | 1 | $0 | 4 | CFO & Head of Corp. Dev. | 02 Feb 2024, 17:08 |
| IKNA | Ikena Oncology, Inc. | 03 Jan 2023 | 1 | $0 | 4 | CFO & Head of Corp. Dev. | 05 Jan 2023, 15:15 |
| IKNA | Ikena Oncology, Inc. | 25 Apr 2022 | 1 | $0 | 4 | CFO & Head of Corp. Dev. | 25 Apr 2022, 18:54 |
| IKNA | Ikena Oncology, Inc. | 25 Apr 2022 | 0 | $0 | 3 | CFO & Head of Corp. Dev. | 25 Apr 2022, 18:48 |
| APTOF | Aptose Biosciences Inc. | 18 Jan 2022 | 1 | $0 | 4 | Senior VP, CFO, and CBO | 20 Jan 2022, 16:17 |
| APTOF | Aptose Biosciences Inc. | 19 Aug 2021 | 2 | $0 | 4 | Senior VP, CFO, and CBO | 23 Aug 2021, 16:57 |